• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Livongo Launches New Direct-to-Consumer Diabetes Management Program

by HITC Staff 05/11/2017 1 Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Livongo Health Raises $52.5M to Expand Diabetes Management to International Markets

Livongo Health, a consumer digital health company focused on empowering people with chronic conditions to live better and healthier lives, today announced partnerships with the American Diabetes Association, Beyond Type 1, Diabetes Hands Foundation, and JDRF to launch the Livongo Family Care Plan. The Family Care Plan is a comprehensive direct-to-consumer diabetes management program for people with diabetes and those who love them.

The partnership also provides everyone who subscribes to the Family Care Plan a groundbreaking way to fund vital research and advocacy programs. Livongo will make a $3 donation every month on behalf of each member who subscribes through Beyond Type 1, Diabetes Hands Foundation, and JDRF. Additionally, Livongo has pledged financial support for the American Diabetes Association’s programs and efforts aimed at underserved diabetes communities.

Livongo’s Family Care Plan combines an advanced, cellular-enabled blood glucose meter with digital tools and personalized messaging, expert support from Certified Diabetes Educators, and unlimited supplies like strips to check blood sugar. It’s also the only program that offers support at critical moments–in real time–for people with diabetes and the people who love them, including the option for text message updates to family members after important glucose readings and 24/7 live outreach when a member’s glucose reading is out of range. The plan costs $49.99 per month, with a minimum 3 month commitment.

“Today, Livongo is launching our efforts by committing over $250,000 to the leading diabetes research, support, and advocacy organizations in support of their mission. Livongo is also introducing an innovative fundraising model to provide recurring funding for research for a cure, and programs to support people with diabetes until we find a cure. We hope to see other diabetes companies commit to increasing support for each of our partners,” said Glen Tullman, Chief Executive Officer for Livongo. “Our goal is to empower people with diabetes to live better and healthier lives, while funding important research, technology, and advocacy programs.”

Individuals can sign up for the Livongo Family Care Plan and support Beyond Type 1, Diabetes Hands Foundation, and JDRF by visiting:

– Beyond Type 1: beyondtype1.livongo.com

– Diabetes Hands Foundation: dhf.livongo.com

– JDRF: jdrf.livongo.com

 

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: diabetes, Diabetes Management, Diabetes Management Platform, digital diabetes management platform, Type 2 Diabetes

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |